Is Celanese Celanese valuation justified? Here I will cover the organisation prospective on valuation to give you a better outlook on taking a position in this stock. What is Celanese Celanese Target Price Odds to finish over Current Price? Pertaining to normal probability distribution, the odds of Celanese Celanese to move above current price in 30 days from now is about 18.43%. The Celanese Corporation Celanese C probability density function shows the probability of Celanese Celanese Stock to fall within a particular range of prices over 30 days . Allowing for the 30-days total investment horizon, Celanese Celanese has beta of 0.5866 . This suggests as returns on market go up, Celanese Celanese average returns are expected to increase less than the benchmark. However during bear market, the loss on holding Celanese Corporation Celanese C will be expected to be much smaller as well. Additionally, the company has an alpha of 0.1471 implying that it can potentially generate 0.1471% excess return over S&P 500 after adjusting for the inherited market risk (beta).
This firm reports 3.99B of total liabilities with total debt to equity ratio (D/E) of 122.5 which implies that the company may not be able to produce enough cash to satisfy its debt commitments. Celanese Celanese dividends can provide a clue to current valuation of the stock. The firm one year expected dividend income is about $1.03 per share. Earning per share calculations of Celanese Celanese is based on official Zacks consensus of 8 analysts regarding the entity future annual earnings. Given the historical accuracy of 96.26%, the future earnings per share of the company is estimated to be 10.3756 with lowest and highest values of 10.0 and 10.58 respectively. Please note that this consensus of annual earnings estimates for the stock is an estimate of EPS before non-recurring items and including employee stock options expenses.
Celanese Corporation Celanese C utilizes its assets nearly 7.39 percent, earning $0.0739 for each dollar of assets held by the firm. An expanding assets utilization signifies that the company is being more effective with each dollar of assets it shows. In plain English assets utilization of Celanese Celanese shows how effective it operates for each dollar spent on its assets. The modest gains experienced by current holders of Celanese Celanese could raise concerns from investors as the firm closed today at a share price of
107.59 on
1002366.000 in volume. The company executives have been quite successful with maneuvering the stock at opportune times to take advantage of all market conditions in
July. The stock standard deviation of daily returns for 30 days (very short) investing horizon is currently 1.4643. The below-average Stock volatility is a good sign for a longer term investment options and for buy-and-hold investors. Celanese Celanese maintains return on equity of 30.00% . Celanese Celanese is trading at 109.14 which is 2.54 percent up. Day high is 110.52. Celanese Celanese Price to Book Value is decreasing over the last 4 years. Further, Celanese Celanese Dividend Yield is rather stable at the moment.
| 2015 | 2016 | 2017 | 2018 | 2019 (projected) |
Celanese Celanese Long Term Debt to Equity | 1.04 | 1.12 | 1.15 | 1.00 | 1.62 | Celanese Celanese Interest Coverage | 2.84 | 7.54 | 7.55 | 11.25 | 7.97 |
The bottom line, we believe that at this point Celanese Celanese is very steady with
below average probability of distress within the next 2 years. Our present Buy/Hold/Sell recommendation on the firm is
Strong Buy.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEllen Johnson is a Member of Macroaxis Editorial Board. Ellen covers public companies in North America, focusing primarily on valuation and volatility. Six years of experience in predictive investment analytics and risk management.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of Celanese. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com